Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: "The cost of the drug wasn’t mentioned – a big oversight. Other news stories pegged it at about $35,000 a year. Adequate job. The story explained: ""But experts stress that Benlysta is not a miracle drug: It only worked in 35 percent of North American patients tested and was not effective for patients with the deadliest form of the disease. Additionally, it did not show positive results in African Americans, who are disproportionately affected by lupus."" There was no discussion of harms. An NPR story, by comparison, pointed out that ""There are side effects, of course, and some of them are pretty serious. In clinical tests involving about 2,100 people, 11 taking Benlysta died compared with 4 getting placebo. About 6 percent of people taking Benlysta got serious infections compared with 5.2 percent on placebo."" The story offered an interesting historical perspective on the evidence: ""The company originally tested Benlysta, known generically as belimumab, as a treatment for rheumatoid arthritis. When a mid-stage trial in lupus patients failed to meet researchers’ goals in 2006, many analysts wrote the drug off and downgraded the company’s stock. But when scientists reanalyzed the data they found that the drug helped block the antibodies that cause lupus symptoms in a subset of patients."" No disease mongering of lupus. Two independent sources were quoted. Not applicable. With no other new drug approved for lupus in 56 years, there’s not been much to compare it with. The story did state that some experts thought this ""could prompt development of other drugs that are even more effective in treating the debilitating immune system disorder."" The focus of the story is FDA approval of the new drug. The headline explains that the FDA approved the first new drug for lupus in 56 years. It’s clear the story did not rely solely on a news release." Claim: FDA approves first new drug for lupus in 56 years
[A]: "Good caveats, including in the patient profiled, who said, ""It’s a bittersweet thing for me because I have friends with lupus for whom this drug won’t work. There’s no one-size-fits-all for lupus and I’m just extremely fortunate that my lupus is mild and is helped by Benlysta."" The story should have discussed potential harms and costs. As the story explained, this was not only the first new lupus drug approved in 56 years, but it could be ""a milestone that medical experts say could prompt development of other drugs that are even more effective in treating the debilitating immune system disorder."""


[Q]: Paragraph: The deal would resolve alleged violations of civil environmental statutes, including the Clean Water Act, related to the pollution from a company factory in Waynesboro. It would amount to the largest environmental damage settlement in Virginia history and the eighth largest in the nation, officials said. The money would go to projects including wildlife habitat restoration, water quality enhancement and improvements to recreational areas. “In bringing this settlement to a close, we are finally righting a wrong that has impacted the South River and the South Fork of the Shenandoah River for so many decades,” Democratic Gov. Terry McAuliffe said at a news conference announcing the settlement. Wilmington, Delaware-based Dupont Co. used mercury in its process of making synthetic fiber at the plant between 1929 and 1950, according to the state Department of Environmental Quality. Strict storage and disposal regulations weren’t in place at the time, and some of the mercury seeped into the South River and flowed downstream to the South Fork of the Shenandoah River. DuPont discovered the mercury — which accumulates in fish and is especially dangerous to pregnant or breastfeeding women and young children — in the facility’s soil in 1976, officials say. The pollution impacted over 100 miles of river and thousands of acres of floodplain and riparian habitat, affecting fish, mussels, migratory birds and amphibians, the Department of Justice said in a statement. The pollution also has limited some recreational fishing in Waynesboro, a city of about 20,000 in the Shenandoah Valley. The terms of the settlement are outlined in a proposed consent decree that was filed in federal court in Harrisonburg on Thursday. It is subject to a 45-day public comment period and must be approved by the court. The amount of money proposed is “quite impressive,” but mercury is very persistent in the environment and very difficult to remove, said Dr. Thomas Benzing, a professor of integrated science and technology at James Madison University who works with a team of researchers who have been monitoring the mercury levels since 2001. If the settlement goes forward, DuPont would pay slightly more than $42 million toward projects including streamside plantings and erosion control to improve water quality and fish habitat; mussel propagation and restoration; migratory songbird habitat restoration and protection; and recreational fishing access creation or improvement. The company also will pay for renovations at the Front Royal Fish Hatchery to improve production of warm-water fish such as smallmouth bass, at an estimated cost of up to $10 million. “Every dollar is going to be used to clean up the land, the source issues and the water, to where it would have been” if not for the pollution, said Assistant Attorney General John Cruden of the Justice Department’s Environmental and Natural Resources Division. No one from DuPont — which is awaiting final regulatory approval for its merger with Dow Chemical in a deal to create DowDuPont, a $130 billion conglomerate — spoke at the announcement. But Mike Liberati, South River project director for the DuPont Corporate Remediation Group, said in a statement that DuPont “is committed to a long-term presence in the Waynesboro area and to maintaining transparency with its citizens.” The first phase of remediation, involving part of the riverbank in Waynesboro’s Constitution Park could be complete in February. Soil there containing the highest concentrations of mercury is being excavated and hauled away and replaced by clean topsoil, Liberati said. “It’s going to be a long-term project. It’s not something that’s going to happen overnight,” Benzing said. Claim: DuPont to pay $50M over mercury-contaminated Virginia rivers.
[A]: Chemical giant DuPont will pay more than $50 million but admit no fault under a proposed environmental settlement after releasing toxic mercury for decades that made its way into Shenandoah Valley waterways, state and federal officials announced Thursday.


[Q]: Paragraph: The number of women and girls using contraceptives in 69 of the world’s poorest countries surpassed 317 million in 2018, representing 46 million more users than in 2012, said the report by Family Planning 2020, a U.N.-backed global advocacy group working to promote rights-based family planning. Access to modern contraception helped prevent over 119 million unintended pregnancies and averted 20 million unsafe abortions between July 2017 and July 2018, although populations continue to soar across Africa and other low income countries, the report said. “The best way to overcome this challenge of rapid population growth is by giving women and girls (the) opportunity to decide how many children they want to have,” Beth Schlachter, executive director of Family Planning 2020, told The Associated Press. The mix of contraceptive methods has improved significantly in 20 of the surveyed countries, “meaning that more women are able to find the short-term, long-acting, emergency, or permanent method that suits their needs and preferences,” the report said. But even as millions of poor women use contraceptives, millions more who want to delay or prevent pregnancy are still unable to access it, often due to lack of information, the report said, citing perceived health side-effects and social disapproval as deterrents. Under Family Planning 2020, which grew out of a summit on family planning held in London in 2012, donors have pledged millions of dollars to bring contraception to 120 million more women and girls in developing countries by the year 2020. Many of the 69 countries surveyed for the report are in sub-Saharan Africa, which is witnessing a population boom even as other parts of the world see dropping birth rates. Over half of the global population growth between now and 2050 will take place in Africa, according to U.N. figures. According to the new report, contraceptive use is growing fastest in Africa, even though the region’s fertility rates remain high. The most recent U.N. global population report estimates Africa’s fertility rate to be 5.1 births per woman. Because the region’s growing population is not backed by substantial rises in family incomes and the development of public infrastructure, there are concerns that a population boom may deepen poverty levels for many Africans. Over the years, family planning has often been difficult to sell in heavily paternalistic sub-Saharan Africa, with the matter becoming controversial as some African leaders challenge the view that a growing population is bad for the world’s poorest continent. Ugandan President Yoweri Museveni insists Africa needs more people, and has lambasted what he calls “the shrill cries of NGOs about population control.” In February President John Magufuli of Tanzania encouraged polygamy, citing the 10 million more women than men in his country in advising men to marry “two or more wives” to reduce the number of single women. ___ Muhumuza reported from Kampala, Uganda. Claim: More women in poor countries use contraception, says report.
[A]:
More women and girls in poor countries are using modern contraception, signifying progress in efforts to involve women in family planning, according to a report released Monday.